<DOC>
	<DOCNO>NCT00314613</DOCNO>
	<brief_summary>Assured treatment Risperal CONSTA provide first-episode patient , great potential therapeutic response , best opportunity continue improvement cognitive function beyond three month treatment .</brief_summary>
	<brief_title>Functional Brain Imaging Employment First-Episode Psychotic Patients Treated With Risperdal</brief_title>
	<detailed_description>First episode patient great potential therapeutic response multi-episode patient , many also havea great desire rejoin workforce . Unfortunately , first episode patient become non-compliant intermittently compliant prescribe antipsychotic treatment least frequently multi-episode patient . We believe assure treatment Risperal CONTSTA provide first episode patient wiwth best opporutnity continue improvement cognitive function beyond 3 month treatment improvement cognitive function associate great likelihood employment , real-world outcome , independent living , well measure brain function .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>male female 1840 year age meet DSMIV criterion firstepisode schizophreniform , schizophrenia schizoaffective disorder pregnant &amp; breastfeed woman patient know sensitivity oral Risperdal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Schizophreniform ; Schizophrenia ; Schizoaffective Disorders</keyword>
</DOC>